# Organizational readiness and  engagement of community  oncology practices in implementing tobacco use assessment and treatment

> **NIH NIH R01** · MASSACHUSETTS GENERAL HOSPITAL · 2021 · $129,375

## Abstract

PROJECT SUMMARY/ABSTRACT
 Smoking remains a leading cause of preventable premature disease, disability, and death in the United
States. Tobacco use assessment and treatment is important for individuals with cancer diagnoses, because
persistent smoking can increase illness burden and contribute to negative treatment outcomes. Although the
National Comprehensive Cancer Network (NCCN) recommends evidence-based tobacco use assessment and
treatment, the actual delivery of smoking cessation in the context of cancer care has been inconsistent. Few
studies have examined how organizational level factors influence the adoption of NCCN guidelines for smoking
cessation in oncology practices. Community based oncology networks serve diverse populations including
rural, economically/socially disadvantaged, racial and ethnic minorities, and low-resourced communities. We
propose to enhance the clinical trial for the parent grant, “Implementing A Virtual Tobacco Treatment in
Community Oncology Practices” (R01CA214427; MPIs Dr. Park and Dr. Ostroff) by: 1) examining
organizational contexts that influence adoption of tobacco treatment interventions in cancer care settings; and
2) identifying strategies to facilitate implementation of tobacco use assessment and treatment in NCORP
cancer Community Sites and Minority/Underserved Community Sites enrolled in the parent R01 trial.
Quantitative research methods will be used to explore the association between organizational readiness to
implement tobacco use assessment and treatment and the capacity for cancer care delivery in NCORP
community oncology practices. Using a mixed methods approach, we will evaluate sub affiliate level
engagement, assess barriers and facilitators to community-engaged research (CEnR), and identify potential
implementation strategies to improve adoption of tobacco use assessment and treatment in community
oncology settings with a focus on understanding variation among the NCORP sites participating in the SSS 2.0
trial. The significance of this project is its contribution to the limited knowledge about contextual factors
influencing the adoption of tobacco use assessment and treatment in community oncology settings. This
project will also identify how best to engage community oncology sub affiliates and inform strategies for
improving adoption and integration of smoking cessation in community oncology practices. Findings will inform
the design of a planned large-scale type III hybrid implementation trial that will test various implementation
strategies for developing systems for tobacco use documentation and improving adoption of tobacco use
assessment and treatment in community oncology settings.

## Key facts

- **NIH application ID:** 10274351
- **Project number:** 3R01CA214427-04S1
- **Recipient organization:** MASSACHUSETTS GENERAL HOSPITAL
- **Principal Investigator:** Jamie S. Ostroff
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $129,375
- **Award type:** 3
- **Project period:** 2018-02-01 → 2023-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10274351

## Citation

> US National Institutes of Health, RePORTER application 10274351, Organizational readiness and  engagement of community  oncology practices in implementing tobacco use assessment and treatment (3R01CA214427-04S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10274351. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*